➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Moodys
McKinsey
Dow
Mallinckrodt

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Litigation Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)


Email this page to a colleague

« Back to Dashboard

CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)

Small Molecule Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , and ⤷  Free Forever Trial .
Biologic Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED

Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 168 Letter judgment of non-infringement of U.S. Patent No. 8,828,427 B2 (“’427 patent”). At the …judgment of non-infringement of U.S. Patent No. 8,828,427 (“’427 patent”); WHEREAS, on May 11…summary judgment of non-infringement of the ’427 patent (“Joint Letter concerning summary judgment…5 PageID: 4303 non-infringement of the ’427 patent by May 25, 2018 (17-3159 ECF No. 89, Text Order…summary judgment of non-infringement of the ’427 patent, and wish to join in the joint letter to be submitted External link to document
2018-06-04 171 antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ … United States Patent (10) Patent No.: … (45) Date of Patent: Sep.9,2014 (54)… U.S. PATENT DOCUMENTS Hopatcong, OH … FOREIGN PATENT DOCUMENTS ( *) Notice: Subject to External link to document
2018-08-29 211 Statement Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of United States Patent No. 6,045,501 …Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of U.S. Patent No. 6,045,501 at o Claims, Abstract, … • U.S. Patent No. 6,045,501: External link to document
2018-10-05 227 Exhibits 1-15 (Part 1) antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ …Claims of U.S. Patent Nos. 8,198,262 (“the ’262 patent”), 8,673,939 (“the ’939 patent”), 8,735,4288,735,428 (“the ’428 patent”), and 8,828,427 (“the ’427 patent”) (collectively, “the Patents-in-Suit”). …clients. One of the patents 3 is a formulation patent. It's a very specific…): Patent Asserted Claims ’262 patent [DEFS_POM_ External link to document
2018-10-24 237 5,635,517 (“the ’517 patent”), claims 18-26 of U.S. Patent No. 6,281,230 (“the ’230 patent”), claims 10-…same disclosures as prior art patent U.S. Patent No. 6,281,230, titled “Isoindolines, Method of Use… of this and other IMiDs,” and that U.S. Patent No. 6,281,230 also “covers use of Revimid… to treat…the extent the ’363 patent, ’569 patent, ’498 patent, ’621 patent and ’622 patent expire after…Furthermore, each of the ’471 patent, ’653 patent, ’052 patent, and the ’517 patent are presently or have External link to document
2018-11-14 250 705 3 9 6,045,501 04/04/00 Elsayed, et al. … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…Pleading PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements…examine your submission related to a patent application or patent. If you do not furnish the requested External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Johnson and Johnson
McKinsey
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.